Artivion to Participate in Upcoming Investor Conferences

Rhea-AI Summary

Artivion, Inc. (NYSE: AORT), a leader in cardiac and vascular surgery, announced its participation in two investor conferences. The first is the Morgan Stanley 20th Annual Global Healthcare Conference on September 13, 2022, where a live webcast of the presentation will start at 4:05 p.m. ET. The second is the Lake Street 6th Annual Best Ideas Growth Conference on September 14, 2022, with no webcast available. Artivion focuses on developing solutions for aortic diseases and offers products like aortic stent grafts and On-X mechanical heart valves.

ATLANTA, Sept. 6, 2022 /PRNewswire/ -- Artivion, Inc. (NYSE: AORT), a leading cardiac and vascular surgery company focused on aortic disease, today announced that it will participate in two upcoming investor conferences.

Artivion's management team will present at the upcoming Morgan Stanley 20^th Annual Global Healthcare Conference on Tuesday, September 13, 2022 at the Sheraton New York Hotel. The Company's presentation is scheduled to begin at 4:05 p.m. ET. A live webcast can be accessed through Artivion's website, www.artivion.com, on the Investors page.  An archived copy of the webcast will be available for 90 days on the same website. 

Members of the management team will also participate in investor meetings at the Lake Street 6^th Annual Best Ideas Growth Conference on Wednesday, September 14, 2022. Due to the format of this event no webcast will be available.

About Artivion, Inc.
Headquartered in suburban Atlanta, Georgia, Artivion, Inc. is a medical device company focused on developing simple, elegant solutions that address cardiac and vascular surgeons' most difficult challenges in treating patients with aortic diseases. Artivion's four major groups of products include: aortic stent grafts, surgical sealants, On-X mechanical heart valves, and implantable cardiac and vascular human tissues. Artivion markets and sells products in more than 100 countries worldwide. For additional information about Artivion, visit our website, www.artivion.com.

Contacts:
Artivion	Gilmartin Group LLC
D. Ashley Lee	Brian Johnston / Lynn Lewis
Executive Vice President &	Phone: 332-895-3222
Chief Financial Officer	investors@artivion.com
Phone: 770-419-3355

View original content to download multimedia:https://www.prnewswire.com/news-releases/artivion-to-participate-in-upcoming-investor-conferences-301618599.html

SOURCE Artivion, Inc.

FAQ

What investor conferences will Artivion participate in?

Artivion will participate in the Morgan Stanley 20th Annual Global Healthcare Conference on September 13, 2022, and the Lake Street 6th Annual Best Ideas Growth Conference on September 14, 2022.

When is Artivion's presentation at the Morgan Stanley Conference?

Artivion's presentation at the Morgan Stanley 20th Annual Global Healthcare Conference is scheduled for September 13, 2022, at 4:05 p.m. ET.

Will there be a webcast for Artivion's conference presentations?

Yes, a live webcast of Artivion's presentation at the Morgan Stanley Conference will be available on their website, while no webcast will be available for the Lake Street Conference.

What products does Artivion offer?

Artivion develops products for aortic diseases, including aortic stent grafts, surgical sealants, On-X mechanical heart valves, and implantable cardiac and vascular human tissues.

Where is Artivion headquartered?

Artivion is headquartered in suburban Atlanta, Georgia.